The field of oncology has seen a number of significant advances in recent years. The considerable number of positive reports from the 2019 Congress of the European Society for Medical Oncology (ESMO) last month clearly reflected the meeting’s theme — the translation of scientific advances into better cancer care. AstraZeneca/Merck was one of stars...
The original vision of “personalized medicine” focused on tailoring medications to the biology of the individual patient — treating them with the right drug at the right time. That view has since evolved beyond therapy selection to increasingly encompass aspects of drug discovery, planning and delivery of care, and patient engagement. This new approach, now...